Literature DB >> 20443020

Development and pilot phase of a European MS register.

Peter Flachenecker1, Laura Khil, Sverrir Bergmann, Mariusz Kowalewski, Ion Pascu, Francisco Pérez-Miralles, Jaume Sastre-Garriga, Thomas Zwingers.   

Abstract

The MS-ID (Multiple Sclerosis Information Dividend) project was initiated by the European Multiple Sclerosis Platform (EMSP) in 2007 in order to identify and address major inequalities of MS treatment and care and thus eliminate disparities across the EU. One major approach to reach these goals in the longer term is the implementation of a European MS register for MS. The feasibility of an EU MS register was piloted among five countries (Germany, Iceland, Poland, Romania and Spain). Each country liaised with one documentation centre. Countries and test centres were both chosen in a way that a heterogeneous health care structure was provided. After reaching consensus about the data set, comprehension and acceptability of the two questionnaires-representing both the physician's and the patient's perspective-were tested with 20 MS patients in each country. In a 6-month data collection period, data from 547 patients were recorded. Most sections of the questionnaires were available for more than 90% of patients. The results obtained from the pilot phase of the European MS register indicate that it is feasible to collect standardized data across Europe. Thus, the European MS register may be a valuable instrument to compare treatment and care of MS across countries, estimate the cost of MS in Europe and monitor the implementation of and adherence to guidelines. It may help to reduce the disparities in MS care and treatment throughout Europe and eventually improve the quality of life of people with MS.

Entities:  

Mesh:

Year:  2010        PMID: 20443020     DOI: 10.1007/s00415-010-5578-4

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  15 in total

Review 1.  Databases in MS research: pitfalls and promises.

Authors:  B G Weinshenker
Journal:  Mult Scler       Date:  1999-08       Impact factor: 6.312

2.  [MS registry in Germany--design and first results of the pilot phase].

Authors:  P Flachenecker; U K Zettl; U Götze; J Haas; S Schimrigk; W Elias; M Pette; M Eulitz; M Hennig; J Bertram; R Hollweck; A Neiss; M Daumer; D Pitschnau-Michel; P Rieckmann
Journal:  Nervenarzt       Date:  2005-08       Impact factor: 1.214

3.  Estimation of the cost of MS in Europe: extrapolations from a multinational cost study.

Authors:  P Sobocki; M Pugliatti; K Lauer; G Kobelt
Journal:  Mult Scler       Date:  2007-07-10       Impact factor: 6.312

4.  Basic and escalating immunomodulatory treatments in multiple sclerosis: current therapeutic recommendations.

Authors:  H Wiendl; K V Toyka; P Rieckmann; R Gold; H-P Hartung; R Hohlfeld
Journal:  J Neurol       Date:  2008-10-29       Impact factor: 4.849

5.  Treatment patterns of multiple sclerosis patients: a comparison of veterans and non-veterans using the NARCOMS registry.

Authors:  Albert C Lo; Olympia Hadjimichael; Timothy L Vollmer
Journal:  Mult Scler       Date:  2005-02       Impact factor: 6.312

6.  Costs and quality of life of multiple sclerosis in Germany.

Authors:  Gisela Kobelt; Jenny Berg; Peter Lindgren; W G Elias; P Flachenecker; M Freidel; N König; V Limmroth; E Straube
Journal:  Eur J Health Econ       Date:  2006-09

7.  Symptomatology of MS: results from the German MS Registry.

Authors:  Kristin Stuke; Peter Flachenecker; Uwe K Zettl; Wolfgang G Elias; Matthias Freidel; Judith Haas; Dorothea Pitschnau-Michel; Sebastian Schimrigk; Peter Rieckmann
Journal:  J Neurol       Date:  2009-07-23       Impact factor: 4.849

8.  Multiple sclerosis in Iceland, with observations on the alleged epidemic in the Faroe Islands.

Authors:  J Benedikz; H Magnússon; G Guthmundsson
Journal:  Ann Neurol       Date:  1994-12       Impact factor: 10.422

9.  Change in MS-related disability in a population-based cohort: a 10-year follow-up study.

Authors:  S J Pittock; W T Mayr; R L McClelland; N W Jorgensen; S D Weigand; J H Noseworthy; B G Weinshenker; M Rodriguez
Journal:  Neurology       Date:  2004-01-13       Impact factor: 9.910

Review 10.  National MS registries.

Authors:  Peter Flachenecker; Kristin Stuke
Journal:  J Neurol       Date:  2008-12       Impact factor: 4.849

View more
  5 in total

1.  Emerging evidence-based physical rehabilitation for multiple sclerosis - towards an inventory of current content across Europe.

Authors:  Kamila Rasova; Peter Feys; Thomas Henze; Hans van Tongeren; Davide Cattaneo; Johanna Jonsdottir; Alena Herbenova
Journal:  Health Qual Life Outcomes       Date:  2010-07-28       Impact factor: 3.186

2.  Future MS care: a consensus statement of the MS in the 21st Century Steering Group.

Authors:  Peter Rieckmann; Alexey Boyko; Diego Centonze; Alasdair Coles; Irina Elovaara; Eva Havrdová; Otto Hommes; Jacques Lelorier; Sarah A Morrow; Celia Oreja-Guevara; Nick Rijke; Sven Schippling
Journal:  J Neurol       Date:  2012-08-31       Impact factor: 4.849

Review 3.  Midkine in inflammation.

Authors:  Ludwig T Weckbach; Takashi Muramatsu; Barbara Walzog
Journal:  ScientificWorldJournal       Date:  2011-12-27

4.  A comparative study on iMed(©) and European database for multiple sclerosis to propose a common language of multiple sclerosis data elements.

Authors:  Sima Ajami; Golchehreh Ahmadi; Sakineh Saghaeiannejad-Isfahani; Masoud Etemadifar
Journal:  J Educ Health Promot       Date:  2014-11-29

Review 5.  The role of information system in multiple sclerosis management.

Authors:  Sima Ajami; Golchehreh Ahmadi; Masoud Etemadifar
Journal:  J Res Med Sci       Date:  2014-12       Impact factor: 1.852

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.